4-butyrolactone has been researched along with Endometrial Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aarestrup, J; Christensen, J; Johnsen, NF; Knudsen, KE; Kristensen, M; Kyrø, C; Olsen, A; Overvad, K; Tjønneland, A; Weiderpass, E; Würtz, AM | 1 |
Iida, K; Ishibashi, T; Ishikawa, M; Katagiri, A; Katagiri, H; Miyazaki, K; Nakayama, K; Rahman, M; Rahman, MT | 1 |
Adlercreutz, H; Afanasyeva, Y; Arslan, AA; Berrino, F; Hallmans, G; Johansson, I; Kaaks, R; Koenig, KL; Krogh, V; Lenner, P; Lukanova, A; Lundin, E; Micheli, A; Muti, P; Rinaldi, S; Shore, RE; Stattin, P; Toniolo, P; Zeleniuch-Jacquotte, A | 1 |
Adlercreutz, H | 1 |
1 review(s) available for 4-butyrolactone and Endometrial Neoplasms
Article | Year |
---|---|
Lignans and human health.
Topics: 4-Butyrolactone; Animals; Cardiovascular Diseases; Colorectal Neoplasms; Dietary Fiber; Edible Grain; Endometrial Neoplasms; Feeding Behavior; Female; Health Status; Humans; Isoflavones; Lignans; Male; Phytoestrogens; Plants, Edible; Prostatic Neoplasms; Seeds; Vegetables | 2007 |
3 other study(ies) available for 4-butyrolactone and Endometrial Neoplasms
Article | Year |
---|---|
Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women.
Topics: 4-Butyrolactone; Cohort Studies; Denmark; Diet Surveys; Endometrial Neoplasms; Female; Fluoroimmunoassay; Hormone Replacement Therapy; Humans; Incidence; Lignans; Middle Aged; Phytoestrogens; Proportional Hazards Models; Surveys and Questionnaires | 2013 |
Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
Topics: 4-Butyrolactone; Blotting, Western; Carcinoma, Endometrioid; Cell Proliferation; Endometrial Neoplasms; Fatty Acid Synthase, Type I; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Staging; Prognosis; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Survival Rate; Tumor Cells, Cultured | 2013 |
Circulating enterolactone and risk of endometrial cancer.
Topics: 4-Butyrolactone; Adult; Aged; Biomarkers, Tumor; Case-Control Studies; Endometrial Neoplasms; Female; Humans; Italy; Lignans; Middle Aged; New York; Odds Ratio; Prospective Studies; Risk Assessment; Risk Factors; Sweden | 2006 |